Validus Holdings, Ltd. (NYSE:VR) Director Michael E.A. Carpenter sold 10,000 shares of the business’s stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $67.70, for a total transaction of $677,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Shares of Validus Holdings, Ltd. (NYSE VR) traded up $0.14 on Wednesday, reaching $67.50. 585,338 shares of the company were exchanged, compared to its average volume of 2,183,803. Validus Holdings, Ltd. has a twelve month low of $41.15 and a twelve month high of $67.79. The firm has a market cap of $5,370.34, a price-to-earnings ratio of -78.49, a P/E/G ratio of 1.79 and a beta of 1.02. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.90 and a current ratio of 0.90.
Validus (NYSE:VR) last announced its quarterly earnings results on Thursday, February 1st. The insurance provider reported $0.05 EPS for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($1.00). Validus had a negative net margin of 1.70% and a negative return on equity of 1.85%. The company had revenue of $346.88 million during the quarter, compared to analyst estimates of $352.00 million. During the same quarter last year, the company posted $0.80 EPS. The firm’s quarterly revenue was up 16.1% on a year-over-year basis. analysts anticipate that Validus Holdings, Ltd. will post 4.2 earnings per share for the current year.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Xact Kapitalforvaltning AB acquired a new position in Validus in the 4th quarter valued at about $318,000. Delek Group Ltd. acquired a new position in Validus in the 4th quarter valued at about $7,963,000. Vident Investment Advisory LLC acquired a new position in Validus in the 4th quarter valued at about $232,000. Laurel Wealth Advisors Inc. grew its stake in Validus by 13.2% in the 4th quarter. Laurel Wealth Advisors Inc. now owns 10,671 shares of the insurance provider’s stock valued at $500,000 after buying an additional 1,241 shares during the last quarter. Finally, Zeke Capital Advisors LLC acquired a new position in Validus in the 4th quarter valued at about $566,000. Institutional investors and hedge funds own 98.97% of the company’s stock.
Several research analysts have recently weighed in on the stock. Buckingham Research lowered shares of Validus from a “buy” rating to a “neutral” rating in a research note on Tuesday, February 13th. JMP Securities lowered shares of Validus from an “outperform” rating to a “market perform” rating in a research note on Tuesday, January 30th. Keefe, Bruyette & Woods lowered shares of Validus from an “outperform” rating to a “market perform” rating in a research note on Monday, January 22nd. Zacks Investment Research lowered shares of Validus from a “hold” rating to a “sell” rating in a research note on Saturday, January 13th. Finally, Barclays restated a “hold” rating and set a $50.00 price objective on shares of Validus in a research note on Tuesday, January 9th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $52.80.
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.